Skip to content

Effects of Lean Beef Consumption on Cardiometabolic Health and Gut Microbiome

Effects of Lean Beef Consumption on Cardiometabolic Health and Gut Microbiome

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06433115
Enrollment
90
Registered
2024-05-29
Start date
2024-06-11
Completion date
2027-12-01
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet Intervention

Brief summary

This study is investigating the benefits of lean beef consumption on cardiometabolic health and gut microbiome.

Detailed description

The study is a 6-wk randomized, controlled, and parallel arm clinical trial. Participants will be randomized to consume either lean grain-fed beef, lean grass-fed beef, or plant-based meat for 6 weeks. Outcomes assessed will include metabolic, inflammatory, and gut microbiome markers.

Interventions

OTHERLean (≥90%) Grass-Fed Beef

The specified amount will be 4 oz. per day or 28 ounces per week for participants with an energy requirement of 2000 kcal.

OTHERLean (≥90%) Grain-Fed Beef

The specified amount will be 4 oz. per day or 28 ounces per week for participants with an energy requirement of 2000 kcal.

OTHERPlant-Based Meat

Plant-based meat would be macronutrient matched to the same quantities of meat prescribed for a given energy level.

Sponsors

University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Single Blind

Intervention model description

Parallel Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 18-45 years of age * BMI: 18-35 kg/m2 * Willingness to consume study foods. * Willing to comply with study protocol. * Consistent diet and activity patterns for 4 weeks * Weight stable (≤5 kg change over the last 3 months) * Non-smoker \>1 year or more

Exclusion criteria

* Allergies to foods provided in the study * Diabetes * Gastrointestinal disease and/or bariatric surgery * Uncontrolled hypertension and blood pressure ≥ 180/110 * Illicit drug use * Recent consumption of antibiotics or probiotics * Recent start of medications that affect metabolism or appetite. * Recent blood donation * Drug therapy for coronary artery disease, peripheral artery disease, congestive - heart failure, or dyslipidemia * Pregnant or lactating individuals * Taste or smell disorders * High consumers of red meat or plant-based meat (≥ 4 times/week)

Design outcomes

Primary

MeasureTime frameDescription
Gut microbial alpha-diversityBaseline, week 6Assessed via16S rRNA sequencing
Interleukin-6 concentrationsBaseline, week 6Inflammatory marker
LDL-C concentrationsBaseline, week 6Lipid profile

Secondary

MeasureTime frameDescription
Healthy eating index scoreBaseline, week 6NCI diet history questionnaire
HDL-C concentrationsBaseline, week 6Lipid profile
Total cholesterol concentrationsBaseline, week 6Lipid profile
Triglyceride concentrationsBaseline, week 6Lipid profile
Gut microbiome abundanceBaseline, week 616S rRNA sequencing
LPS-binding protein concentrationBaseline, week 6Intestinal permeability marker
Glucose concentrationsBaseline, week 6Blood Glucose
Insulin concentrationsBaseline, week 6Insulin
Taste and flavor intensity ratings of foodsBaselineSensory intensity scales
Fat massBaseline, week 3, and week 6Fat mass
Fat-free massBaseline, week 3, and week 6Fat-free mass
Waist circumferenceBaseline, week 3, and week 6Waist circumference
Hip circumferenceBaseline, week 3, and week 6Hip Circumference
Thigh circumferenceBaseline, week 3, and week 6Thigh Circumference
24 hour appetite ratingsBaseline, week 624-hour appetite ratings assessed on VAS
Physical activity scoresBaseline, week 6Activity assessment using Actigraphs
Total hours of sleepBaseline, week 6Sleep diary
Palatability rating of foodsBaseline, week 3, week 6Hedonic general labelled magnitude scale (gLMS)
Acceptance rating of foodsBaseline, week 3, week 69-point food action rating scale
Body massBaseline, week 3, and week 6Measured in kg
Gene expression levelsBaseline, week 6Transcriptomics analyses
Inflammatory marker concentrationsBaseline, week 6Inflammatory markers

Other

MeasureTime frameDescription
Nutrient intakesBaseline, week 3, week 624 hours dietary recall
Metabolite intensitiesBaseline, week 6Untargeted and targeted metabolomics

Countries

United States

Contacts

Primary ContactJaapna Dhillon
jdhillon@missouri.edu573-884-2103

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026